Society
Prison Recalls Exceed Releases in England and Wales
•Prison recall rate surpasses 100% for first time in England and Wales. Q1 2026 data shows 13,193 recalls versus 12,977 releases, up 31% year-over-year.
1 August 2026
Section
Society
Society
NHS Ends Medical Training Initiative for International Doctors
•NHS England cancels overseas doctor placement scheme that trained 400-500 international physicians annually. Medical colleges criticize the decision affecting g...
1 August 2026
Society
Prison Recalls Exceed Releases in England and Wales
•England and Wales hit historic milestone: more prisoners recalled than released in Q1 2026. Licence breaches surge 31% amid capacity crisis.
1 August 2026
Society
NHS Terminates Overseas Doctor Training Initiative Amid Criticism
•Medical Training Initiative scrapped: NHS ends placement scheme for 400-500 foreign doctors yearly, drawing condemnation from senior physicians over lost soft p...
1 August 2026
Society
NHS Ends Overseas Doctor Training Program
•NHS England scraps Medical Training Initiative, eliminating 400-500 annual placements for foreign-trained doctors in UK hospitals.
1 August 2026
Society
UK Hospitals End Medical Training Program for Foreign Doctors
•NHS England terminates overseas doctor placement scheme attracting 400-500 annually. Medical colleges oppose decision affecting international physician training...
1 August 2026
Society
NHS Eliminates Training Initiative for International Medical Professionals
•NHS England terminates Medical Training Initiative that annually hosted 400-500 overseas doctors. Medical colleges express concerns over loss of international c...
1 August 2026
Society
NHS Eliminates Overseas Doctor Training Initiative Scheme
•NHS scraps Medical Training Initiative that placed 400-500 foreign doctors yearly. Medical colleges criticize decision affecting international physician develop...
1 August 2026
Society
Lenacapavir: el fármaco inyectable que podría revolucionar la prevención del VIH globalmente
•Expertos advierten que los cortes de USAID impiden el acceso a lenacapavir, un fármaco inyectable revolucionario para la prevención del VIH que podría reducir s...
1 August 2026
Society
Injectable PrEP Drug Offers HIV Prevention Hope Amid Funding Crisis
•Injectable lenacapavir shows 99% effectiveness for HIV prevention globally, but USAID funding cuts threaten access to vulnerable populations worldwide.
1 August 2026
Society
Injectable PrEP Drug Offers Hope But USAID Cuts Threaten Global HIV Prevention
•Injectable lenacapavir shows promise for HIV prevention worldwide, yet funding cuts limit access. Experts warn of setbacks in fighting the epidemic at Aids 2026...
1 August 2026
Society
Injectable HIV Prevention Drug Faces Access Crisis Amid USAID Cuts
•Lenacapavir injectable PrEP offers 99% HIV prevention effectiveness, but USAID funding cuts threaten global access. Experts warn of widening health disparities.
1 August 2026
Society
Injectable PrEP Drug Offers Global Hope Against HIV, Yet USAID Cuts Block Access
•Lenacapavir injectable PrEP shows promise for reducing HIV cases worldwide, but USAID funding cuts threaten access in vulnerable regions. Expert insights from A...
1 August 2026
Society
Lenacapavir Injectable Could Cut HIV Cases Globally
•Injectable lenacapavir shows promise for HIV prevention worldwide, but USAID funding cuts threaten access to vulnerable populations, experts warn.
1 August 2026
Society
Court Authorizes Puberty Blocker Clinical Trial Research Study
•High court approves King's College London clinical trial on puberty blockers for children after rejecting legal challenge regarding participant safety concerns.
1 August 2026
Society
Court Approves Puberty Blocker Clinical Trial at King's College London
•High court judge dismisses legal challenge against King's College London clinical trial studying puberty blockers in children. Research can now proceed.
1 August 2026
Society
Court Approves Puberty Blocker Clinical Trial at King's College
•High court judge dismisses legal challenge against King's College London puberty blocker research study, allowing clinical trial to proceed with children partic...
1 August 2026
Society
Court Approves Puberty Blocker Trial at King's College London
•High court judge rejects legal challenge against King's College London clinical trial on puberty blockers. Trial can now proceed after court ruling.
1 August 2026